日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients

CHEOPS试验:一项由GINECO组开展的随机II期临床试验,旨在评估在既往接受过治疗的转移性乳腺癌患者中,口服长春瑞滨联合非甾体类芳香化酶抑制剂的疗效。

Bailleux, Caroline; Arnaud, Antoine; Frenel, Jean-Sébastien; Chabaud, Sylvie; Bachelot, Thomas; You, Benoît; Stefani, Laëtitia; Tixidre, Claire Garnier; Simon, Hélène; Beal-Ardisson, Dominique; Jacquin, Jean-Philippe; Del Piano, Francesco; Lortholary, Alain; Cornea, Claudiu; Greilsamer, Charlotte; Largillier, Rémy; Brocard, Fabien; Legouffe, Eric; Atlassi, Mustapha; Hardy-Bessard, Anne-Claire; Heudel, Pierre-Etienne

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab

基线肿瘤大小是接受一线帕博利珠单抗治疗的PD-L1 ≥ 50%非小细胞肺癌患者总生存期的独立预后因素

Bureau, Mathilde; Chatellier, Thierry; Perennec, Tanguy; Goronflot, Thomas; Greilsamer, Charlotte; Chene, Anne-Laure; Affi, Raafet; Frampas, Eric; Bennouna, Jaafar; Pons-Tostivint, Elvire